Últimos días para inscribirse a la carrera ‘Huesca contra el cáncer’
14 octubre, 2026
La participación en el cribado de cáncer de mama en Aragón alcanza el 72%, dos puntos por encima de la referencia que marca la Unión Europea
19 octubre, 2026The European Partnership for Personalised Medicine (EP PerMed), co-funded by the European Union, has announced its Joint Transnational Call 2027, Cell and Gene Therapy for Personalised Medicine (CGT4PM2027).
The call aims to fund innovative, multinational research projects focused on the development and validation of cell and gene therapies for personalised medicine, targeting any human disease.
Proposals should address at least one of the following approaches: somatic cell therapies, gene therapies, combined cell and gene therapies, or novel biological products, including mRNA-based technologies, other nucleic acid-based approaches and extracellular vesicles used as delivery vehicles for gene-based therapies.
This call encourages collaboration between academic, clinical and private research teams and will be implemented in two stages: pre-proposals and full proposals.
Total available budget: approximately EUR 33 million
Call opening: 4 November 2026
Deadline (pre-proposals): 20 January 2027, 14:00 CET
Deadline (full proposals, by invitation): 25 May 2027, 14:00 CEST